CRISPR Therapeutics AG (CRSP) Receivables - Other (2016 - 2024)
CRISPR Therapeutics AG (CRSP) posted Receivables - Other of $2.1 million for Q4 2024, down 67.69% sequentially from $6.5 million in Q4 2023, and down 67.69% YoY from $6.5 million in Q1 2024.
CRISPR Therapeutics AG (CRSP) Receivables - Other (2016 - 2024) Analysis & Trends
CRISPR Therapeutics AG has reported Receivables - Other for 9 years, with the latest figure at $2.1 million in Q4 2024.
- Quarterly Receivables - Other fell 67.69% year-over-year to $2.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $2.1 million (down 67.69% YoY) and the FY2024 annual result came in at $2.1 million, down 67.69% from the prior year.
- Receivables - Other fell to $2.1 million in Q4 2024 per CRSP's latest filing, from $6.5 million in the prior quarter.
- Over five years, Receivables - Other peaked at $25.0 million in Q1 2020 and troughed at $2.1 million in Q4 2024.
- A 5-year average of $14.2 million and a median of $11.0 million in 2020 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2020 and 2024: Receivables - Other surged 7688.16% in 2020, then tumbled 67.69% in 2024.
- Over 5 years, Receivables - Other stood at $10.7 million in 2020, then retreated by 21.5% to $8.4 million in 2021, then jumped by 33.33% to $11.2 million in 2022, then slumped by 41.96% to $6.5 million in 2023, then sank by 67.69% to $2.1 million in 2024.
- According to Business Quant data, Receivables - Other over the past three periods registered $2.1 million, $6.5 million, and $11.2 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.10 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 6.50 Mn |
| Dec 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 11.20 Mn |
| Dec 31, 2022 | 11.20 Mn |
| Dec 31, 2021 | 8.40 Mn |
| Dec 31, 2021 | 8.40 Mn |
| Dec 31, 2020 | 10.70 Mn |
| Dec 31, 2020 | 10.70 Mn |
| Sep 30, 2020 | 25.00 Mn |
| Sep 30, 2020 | 25.00 Mn |
| Jun 30, 2020 | 25.00 Mn |
| Jun 30, 2020 | 25.00 Mn |
| Mar 31, 2020 | 25.00 Mn |
| Mar 31, 2020 | 25.00 Mn |
| Dec 31, 2019 | 4.10 Mn |
| Dec 31, 2019 | 4.10 Mn |
| Sep 30, 2019 | 25.00 Mn |
| Sep 30, 2019 | 25.00 Mn |